📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
6
COGT Latest News & AI Sentiment Analysis
1 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 5 ARTICLES
10 Affordable Biotech Stocks to Buy Right Now
This article presents a listicle of affordable biotech equities without substantive market catalysts or fundamental developments. The...
Is Cogent Biosciences (COGT) ’s New Cancer Drug 100 Times More Precise Than What’s Already on the Market?
COGT presented preclinical data for CGT1145, an experimental oncology candidate positioned as substantially more precise than current...
Cogent Biosciences: A Pre-Commercial Biotech With Commercial-Stage Leverage (NASDAQ:COGT)
COGT represents a pre-commercial biotech transitioning toward commercial-stage execution through a focused KIT-mutant franchise...
Cogent Biosciences, Inc. (COGT) Presents at European Hematology Association (EHA) 2026 Congress - Slideshow (NASDAQ:COGT) 2026-06-13
COGT presented clinical or corporate data at the European Hematology Association 2026 Congress, a standard industry conference attended...
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
Cogent Biosciences (COGT) unveiled preclinical efficacy data for its JAK2 V617F inhibitor candidate at a major European hematology...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice